Erlichman Charles MD entered the industry of Medical Research in 2004 and has grown to employ 1 to 4 people, generating an annual revenue of $100.000 to $499.999. The NAICS classifies this business under the code 6211110, which describes it as a Medical Research. For further clarification, the SIC classifies this business under the code 8733 and described it as a Medical Research. The business provides service to the B2B market.
To acquire more information, please contact Charles Erlichman by calling (507) 284-3903 during business hours. You can also write to the business’ Single Location at 200 1st St Sw # W4, Rochester, Minnesota MN 55905. You can also visit the company’s website at mayoclinic.com. View this business’ social media profiles on Twitter or on Facebbok .
| Company: | Erlichman Charles MD |
| Representative: | Charles Erlichman |
| Place of Business: | 200 1st St Sw # W4, Rochester, MN 55905 |
| Contact Number: | (507) 284-3903 |
| Website: | mayoclinic.com |
| Type of Service: | Medical Research |
| SIC Number: | 8733 |
| NAICS Number: | 6211110 |
| Locality: | Single Location |
| Market Type: | B2B (Business to Business) |
| Began: | 2004 |
| Income/Year: | $100.000 to $499.999 |
| Laborers: | 1 to 4 |
| Share This Company: |
Erlichman Charles MD is a company operating from Olmsted, Minnesota providing professional Medical Research and relevant B2B variables. It was founded in 2004 and registered with the SIC code 8733 as Medical Research, and with the NAICS code 6211110 as Medical Research.
With a current employee count of 1 to 4, Erlichman Charles MD has gone to report making $100.000 to $499.999 per annum on its journey towards growth. This company invites you to contact its representative Charles Erlichman at (507) 284-3903 for related queries, or to locate its Single Location using the coordinates 44.03736,-92.49011.
The Single Location can also be found at the street address 200 1st St Sw # W4 in Rochester, Minnesota 55905 and can be engaged online through the company website at mayoclinic.com, the company Twitter , and Facebook page .